Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.777820
Title: The pharmacological evaluation and development of novel anti-cancer compounds
Author: Phillips, Roger Mortimer
ISNI:       0000 0004 7963 5921
Awarding Body: University of Huddersfield
Current Institution: University of Huddersfield
Date of Award: 2019
Availability of Full Text:
Access from EThOS:
Access from Institution:
Abstract:
The work presented in this thesis represents my 'adventures' in the field of cancer pharmacology and drug development. The work has been segregated into six major themes that represent my interests over a career spanning 30 years. These themes are; (i) the preclinical and clinical development of EO9 (Apaziquone) as a loco-regional therapy for non-muscle invasive bladder cancer (ii) the microenvironment of cancer, cancer metabolism and the pharmacological evaluation of enzyme activated bioreductive drugs (iii) individualising chemotherapy and personalized medicine (iv) the pharmacological evaluation of synthetic organic compounds and natural products (v) the pharmacological evaluation of inorganic complexes and (vi) drug delivery and in silico modelling studies. A total of 109 peer reviewed research publications are presented together with 12 review articles, the majority of which have also been peer reviewed. Also included is an impact case study report for the Research Excellence Framework 2014 submission which highlights one area of my research that has had direct impact upon the health and well-being of cancer patients, namely the development of Apaziquone (EO9) as an intravesical therapy for superficial bladder cancer. Working in the field of anti-cancer drug development is inherently multidisciplinary and I hereby wish to acknowledge and thank the contributions of colleagues and students without whom, this thesis would not have been possible.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.777820  DOI: Not available
Keywords: R Medicine (General) ; RM Therapeutics. Pharmacology
Share: